The historical rank and industry rank for TransMedics Group's FCF Margin % or its related term are showing as below:
HAM:8T8'
s FCF Margin % Range Over the Past 10 Years
Min: -412.1 Med: -113.42 Max: 23.79
Current: 23.79
During the past 10 years, the highest FCF Margin % of TransMedics Group was 23.79%. The lowest was -412.10%. And the median was -113.42%.
HAM:8T8's FCF Margin % is ranked better than 94.11% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.34
vs HAM:8T8: 23.79
TransMedics Group FCF Margin % Related Terms
TransMedics Group FCF Margin % Historical Data
* Premium members only.
The historical data trend for TransMedics Group's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAM:8T8 vs AXGN, BFLY, ESTA: FCF Margin % Comparison
For the Medical Devices subindustry, TransMedics Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TransMedics Group FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's FCF Margin % distribution charts can be found below:
* The bar in red indicates where TransMedics Group's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TransMedics Group (HAM:8T8) has a FCF Margin % of -6.97% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on TransMedics Group and its competitors. According to the industry distribution chart, TransMedics Group ranks #48 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 5.9%.
Is TransMedics Group's FCF Margin % too high?
TransMedics Group's current FCF Margin % is -6.97%. Based on the distribution chart, TransMedics Group ranks #48 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, TransMedics Group has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does TransMedics Group's FCF Margin % compare to AXGN and BFLY?
According to the Medical Devices & Instruments industry distribution chart, TransMedics Group ranks #48 out of 815 companies for FCF Margin %. This places TransMedics Group in the top 6% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on TransMedics Group and its competitors. TransMedics Group's current FCF Margin % is -6.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransMedics Group stock overvalued right now?
TransMedics Group (HAM:8T8) has a current FCF Margin % of -6.97%. The stock's GF Value™ is €162.08, compared to a current price of €60.02 — trading 63% below its estimated fair value. The current FCF Margin % is -6.97%. TransMedics Group's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For TransMedics Group (HAM:8T8), the current FCF Margin % is -6.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TransMedics Group (HAM:8T8) Overvalued in 2026?
Based on GuruFocus' analysis, TransMedics Group stock appears to be undervalued.
The current stock price of €60.02 is trading 63% below its estimated GF Value™ of €162.08.
Key valuation signals for HAM:8T8:
FCF Margin %: -6.97%
GF Value™: €162.08 vs. price of €60.02 (63% below fair value)
No single metric tells the full story. See the HAM:8T8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
69GF Score
Get the complete analysis for HAM:8T8
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:8T8 has been successfully added to your 
